Paul Weiss Rifkind Wharton and Garris


Recent News About Paul Weiss Rifkind Wharton and Garris View More

Judge orders new trial, tosses $140M verdict vs AbbVie over Androgel testosterone drug

By Jonathan Bilyk | Jul 5, 2018

A federal judge has knocked down a $140 million verdict against pharmaceutical maker AbbVie, ordering a new trial over a man’s claims AbbVie’s Androgel testosterone replacement therapy drug caused him to suffer a heart attack.

The Record Network